People don't want to face the facts they we don't have an unlimited amount of money and the idiots on Wall Street fuel the fire with even more unrealistic comments. I read where one analyst was talking about Provenge and saying DNDN wasn't charging enough because some drugs cost $200K to $400K per patient. Now those drugs are orphan drugs and the high price was set to enable companies to keep making drugs for a very small patient population. It is absurd and a mark of the delusional greed that fuels Wall Street to use that type of pricing for a large patient population.
Now if the US government decides that the benefits shown by DNDN isn't worth the $93K price tag, DNDN will have to lower the price and accept less profits to get Medicare approval. What a shame.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.